다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Cardiol Therapeutics Inc (CRDL)
Cardiol Therapeutics Inc (CRDL) 뉴스

CRDL Cardiol Therapeutics Inc

1.79

-0.05 (-2.72%)

27 4월(4) 2024 - 마감

기업명	주식 심볼	시장	주식 타입
Cardiol Therapeutics Inc	CRDL	나스닥	보통주

	가격 변동	가격 변동 %	주식 가격	최근 거래 시간
	-0.05	-2.72%	1.79	07:35:35

개장가	저가	고가	종가	전일 종가
1.81	1.74	1.84	1.79	1.84

시세 정보 더보기 »

최근 뉴스

일자	시간	출처	제목
27/02/2024	00:06	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/02/2024	21:29	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/02/2024	03:15	APS	Orphan Drug Designation Sends Shares of this Dual-Listed..
15/02/2024	21:30	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/01/2024	21:29	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/01/2024	21:31	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/12/2023	21:30	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/11/2023	20:01	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/11/2023	20:29	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/10/2023	06:01	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/10/2023	23:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/10/2023	19:01	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/09/2023	20:28	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/09/2023	23:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/09/2023	20:29	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/08/2023	06:13	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/08/2023	21:21	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/08/2023	20:38	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/06/2023	00:44	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..

이 » 주식의 기사 더보기;

Cardiol Therapeutics

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관